{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:59:33Z","timestamp":1791464373836,"version":"4.3.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:00:00Z","timestamp":1593388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004167","name":"Medicines for Malaria Venture","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004167","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Microbiology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.mib.2020.06.004","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T19:36:00Z","timestamp":1594841760000},"page":"49-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["The antimalarial resistome \u2013 finding new drug targets and their modes of action"],"prefix":"10.1016","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6657-0928","authenticated-orcid":false,"given":"Krypton","family":"Carolino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A","family":"Winzeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mib.2020.06.004_bib0005","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.cell.2016.07.055","article-title":"Malaria: biology and disease","volume":"167","author":"Cowman","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.mib.2020.06.004_bib0010","series-title":"World Malaria Report 2018","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.mib.2020.06.004_bib0015","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-1-4939-9550-9_18","article-title":"Insecticides and insecticide resistance","author":"Ndiath","year":"2019","journal-title":"Malar Control Elimination"},{"key":"10.1016\/j.mib.2020.06.004_bib0020","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/nbt.4245","article-title":"A CRISPR-Cas9 gene drive targeting doublesex causes complete population suppression in caged Anopheles gambiae mosquitoes","volume":"36","author":"Kyrou","year":"2018","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.mib.2020.06.004_bib0025","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/nm.4512","article-title":"A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite","volume":"24","author":"Kisalu","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.mib.2020.06.004_bib0030","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.chom.2018.06.008","article-title":"Malaria vaccines: recent advances and new horizons","volume":"24","author":"Draper","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.mib.2020.06.004_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbpa.2019.01.029","article-title":"The antimalarial screening landscape\u2014looking beyond the asexual blood stage","volume":"50","author":"Yahiya","year":"2019","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.mib.2020.06.004_sbref0040","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat9446","article-title":"Open-source discovery of chemical leads for next-generation chemoprotective antimalarials","volume":"362","author":"Antonova-Koch","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.mib.2020.06.004_bib0045","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-05777-2","article-title":"A high throughput screen for next-generation leads targeting malaria parasite transmission","volume":"9","author":"Delves","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.mib.2020.06.004_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2019.02134","article-title":"Fueling open innovation for malaria transmission-blocking drugs: hundreds of molecules targeting early parasite mosquito stages","volume":"10","author":"Delves","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.mib.2020.06.004_bib0055","first-page":"295","article-title":"Functional screening of selective mitochondrial inhibitors of Plasmodium","volume":"8","author":"Gomez-Lorenzo","year":"2018","journal-title":"Int J Parasitol: Drugs Drug Resist"},{"key":"10.1016\/j.mib.2020.06.004_bib0060","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1021\/acsinfecdis.9b00216","article-title":"Identification of small molecules disrupting the ubiquitin proteasome system in malaria","volume":"5","author":"Mata-Cantero","year":"2019","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.mib.2020.06.004_bib0065","doi-asserted-by":"crossref","first-page":"7015","DOI":"10.1073\/pnas.1814685116","article-title":"Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis","volume":"116","author":"Baraga\u00f1a","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.mib.2020.06.004_bib0070","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-019-2665-6","article-title":"Aminoacyl tRNA synthetases as malarial drug targets: a comparative bioinformatics study","volume":"18","author":"Nyamai","year":"2019","journal-title":"Malar J"},{"key":"10.1016\/j.mib.2020.06.004_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2019.144016","article-title":"Genomic and biological features of Plasmodium falciparum resistance against antimalarial endoperoxide N-89","volume":"716","author":"Morita","year":"2019","journal-title":"Gene"},{"key":"10.1016\/j.mib.2020.06.004_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.40529","article-title":"Plasmodium niemann-pick type C1- related protein is a druggable target required for parasite membrane homeostasis","volume":"8","author":"Istvan","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.mib.2020.06.004_bib0085","doi-asserted-by":"crossref","first-page":"10053","DOI":"10.1021\/acs.jmedchem.8b01161","article-title":"Target Validation and identification of novel boronate inhibitors of the Plasmodium falciparum proteasome","volume":"61","author":"Xie","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.mib.2020.06.004_sbref0090","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1126\/science.aan4472","article-title":"Mapping the malaria parasite druggable genome by using in vitro evolution and chemogenomics","volume":"359","author":"Cowell","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.mib.2020.06.004_bib0095","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.chembiol.2017.11.010","article-title":"Specific inhibition of the bifunctional farnesyl\/geranylgeranyl diphosphate synthase in malaria parasites via a new small-molecule binding site","volume":"25","author":"Gisselberg","year":"2019","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.mib.2020.06.004_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-00572-x","article-title":"A potent series targeting the malarial cGMP-dependent protein kinase clears infection and blocks transmission","volume":"8","author":"Baker","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.mib.2020.06.004_bib0105","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau1682","article-title":"Validation of the protein kinase PfCLK3 as a multistage cross-species malarial drug target","volume":"365","author":"Alam","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.mib.2020.06.004_bib0110","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1021\/acsinfecdis.7b00276","article-title":"Using in vitro evolution and whole genome analysis to discover next generation targets for antimalarial drug discovery","volume":"4","author":"Luth","year":"2018","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.mib.2020.06.004_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms6329","article-title":"Versatile control of Plasmodium falciparum gene expression with an inducible protein-RNA interaction","volume":"5","author":"Goldfless","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.mib.2020.06.004_bib0120","doi-asserted-by":"crossref","first-page":"26881","DOI":"10.1073\/pnas.1914732116","article-title":"Evolution of resistance in vitro reveals mechanisms of artemisinin activity in Toxoplasma gondii","volume":"116","author":"Rosenberg","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.mib.2020.06.004_bib0125","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.pt.2018.08.003","article-title":"Plasmodium parasites viewed through proteomics","volume":"34","author":"Swearingen","year":"2018","journal-title":"Trends Parisitol"},{"key":"10.1016\/j.mib.2020.06.004_bib0130","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.tibtech.2018.06.008","article-title":"Chemoproteomics and chemical probes for target discovery","volume":"36","author":"Drewes","year":"2018","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.mib.2020.06.004_bib0135","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1021\/acsinfecdis.7b00228","article-title":"Development of a photo-cross-linkable diaminoquinazoline inhibitor for target identification in Plasmodium falciparum","volume":"4","author":"Lubin","year":"2018","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.mib.2020.06.004_bib0140","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad9735","article-title":"Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase","volume":"9","author":"Paquet","year":"2017","journal-title":"Science Translational Medicine"},{"key":"10.1016\/j.mib.2020.06.004_bib0145","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.exppara.2019.01.008","article-title":"Proteomic analysis of Plasmodium falciparum histone deacetylase 1 complex proteins","volume":"198","author":"Engel","year":"2019","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.mib.2020.06.004_bib0150","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-1-4939-8891-4_4","article-title":"Target engagement of small molecules: thermal profiling approaches on different levels","volume":"1888","author":"Reckzeh","year":"2019","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.mib.2020.06.004_bib0155","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1021\/acsinfecdis.8b00226","article-title":"Pharmacological validation of N-myristoyltransferase as a drug target in Leishmania donovani","volume":"5","author":"Corpas-Lopez","year":"2019","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.mib.2020.06.004_sbref0160","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau3174","article-title":"Identifying purine nucleoside phosphorylase as the target of quinine using cellular thermal shift assay","volume":"11","author":"Dziekan","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.mib.2020.06.004_bib0165","doi-asserted-by":"crossref","DOI":"10.1038\/s41596-020-0310-z","article-title":"Cellular thermal shift assay for the identification of drug\u2013target interactions in the Plasmodium falciparum proteome","author":"Dziekan","year":"2020","journal-title":"Nat Protoc"},{"key":"10.1016\/j.mib.2020.06.004_bib0170","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/2472555219877183","article-title":"High-throughput cellular thermal shift assays in research and drug discovery","volume":"25","author":"Henderson","year":"2020","journal-title":"SLAS Discov"},{"key":"10.1016\/j.mib.2020.06.004_bib0175","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-1-4939-6539-7_2","article-title":"Emerging methods in chemoproteomics with relevance to drug discovery","volume":"1513","author":"Nguyen","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.mib.2020.06.004_bib0180","doi-asserted-by":"crossref","first-page":"6635","DOI":"10.1128\/AAC.01224-16","article-title":"Metabolomic profiling of the malaria box reveals antimalarial target pathways","volume":"60","author":"Allman","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mib.2020.06.004_bib0185","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.chembiol.2019.11.009","article-title":"Combining stage specificity and metabolomic profiling to advance antimalarial drug discovery article combining stage specificity and metabolomic profiling to advance antimalarial drug discovery","volume":"27","author":"Murithi","year":"2020","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.mib.2020.06.004_sbref0190","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aas9917","article-title":"Antimalarial pantothenamide metabolites target acetyl-coenzyme A biosynthesis in Plasmodium falciparum","volume":"11","author":"Schalkwijk","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.mib.2020.06.004_bib0195","doi-asserted-by":"crossref","first-page":"e00097","DOI":"10.1128\/mSphere.00097-18","article-title":"Influential parameters for the analysis of intracellular parasite metabolomics","volume":"3","author":"Carey","year":"2018","journal-title":"mSphere"},{"key":"10.1016\/j.mib.2020.06.004_bib0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-019-2968-7","article-title":"Transcriptome analysis of Plasmodium berghei during exo-erythrocytic development","volume":"18","author":"Caldelari","year":"2019","journal-title":"Malar J"},{"key":"10.1016\/j.mib.2020.06.004_bib0205","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.cell.2019.10.030","article-title":"Genome-scale identification of essential metabolic processes for targeting the plasmodium liver stage","volume":"179","author":"Stanway","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.mib.2020.06.004_bib0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-12936-6","article-title":"Transcriptomics and proteomics reveal two waves of translational repression during the maturation of malaria parasite sporozoites","volume":"10","author":"Lindner","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.mib.2020.06.004_bib0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13073-019-0673-3","article-title":"Advances in omics-based methods to identify novel targets for malaria and other parasitic protozoan infections","volume":"11","author":"Cowell","year":"2019","journal-title":"Genome Med"},{"key":"10.1016\/j.mib.2020.06.004_bib0220","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1021\/acsinfecdis.9b00093","article-title":"Post-genomic approaches to understanding malaria parasite biology: linking genes to biological functions","volume":"5","author":"Sexton","year":"2019","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.mib.2020.06.004_bib0225","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.biopha.2018.05.009","article-title":"Drug targets for resistant malaria: historic to future perspectives","volume":"104","author":"Kumar","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.mib.2020.06.004_bib0230","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1021\/acsinfecdis.7b00211","article-title":"Efforts aimed to reduce attrition in antimalarial drug discovery: a systematic evaluation of the current antimalarial targets portfolio","volume":"4","author":"Chaparro","year":"2018","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.mib.2020.06.004_sbref0235","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw2619","article-title":"The malaria cell atlas: single parasite transcriptomes across the complete Plasmodium life cycle","volume":"365","author":"Howick","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.mib.2020.06.004_bib0240","first-page":"1","article-title":"A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum","volume":"9","author":"Roth","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.mib.2020.06.004_bib0245","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-019-3026-1","article-title":"Antiplasmodial natural products: an update","volume":"18","author":"Tajuddeen","year":"2019","journal-title":"Malar J"},{"key":"10.1016\/j.mib.2020.06.004_bib0250","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev-micro-090817-062427","article-title":"The promise of a malaria vaccine\u2014are we closer?","volume":"72","author":"Laurens","year":"2018","journal-title":"Annu Rev Microbiol"}],"container-title":["Current Opinion in Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1369527420300758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1369527420300758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T05:51:56Z","timestamp":1761285116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1369527420300758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":50,"alternative-id":["S1369527420300758"],"URL":"https:\/\/doi.org\/10.1016\/j.mib.2020.06.004","relation":{},"ISSN":["1369-5274"],"issn-type":[{"value":"1369-5274","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The antimalarial resistome \u2013 finding new drug targets and their modes of action","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mib.2020.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}